0.2821
Finanzdaten der Intensity Therapeutics Inc-Aktie (INTS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
|
20.30%
2.705
|
3.394 | 3.203 | 3.57 | 5.069 |
Operating Income/Loss |
20.30%
-2.705
|
-3.394 | -3.203 | -3.57 | -5.069 |
Income/Loss From Continuing Operations Before Tax |
24.20%
-2.537
|
-3.347 | -3.181 | -3.513 | -4.971 |
Income/Loss From Continuing Operations After Tax |
24.20%
-2.537
|
-3.347 | -3.181 | -3.513 | -4.971 |
|
24.20%
-2.537
|
-3.347 | -3.181 | -3.513 | -4.971 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
24.35%
18.87
|
15.17 | 0.1646 | 13.80 | 13.71 |
Diluted Average Shares |
24.35%
18.87
|
15.17 | 0.1646 | 13.80 | 13.71 |
Basic Earnings Per Share |
40.91%
-0.13
|
-0.22 | -0.22 | -0.25 | -0.36 |
Diluted Earnings Per Share |
40.91%
-0.13
|
-0.22 | -0.22 | -0.25 | -0.36 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):